Patents by Inventor Benoit Gamain

Benoit Gamain has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11147868
    Abstract: The present invention generally relates to an immunogenic construct, useful for redirecting an EBV-existing immune response towards an undesired target cell and/or microorganism, to methods for preparing said conjugate, to a pharmaceutical applications comprising said conjugate, and to medical applications thereof.
    Type: Grant
    Filed: December 15, 2016
    Date of Patent: October 19, 2021
    Assignees: Institut National de la Sante et de la Recherche Medicale (INSERM), Centre National de la Recherche Scientifique (CNRS), Université de Paris, Institut National Transfusion Sanguine
    Inventors: Arnaud Chene, Benoit Gamain, Stéphane Gangnard
  • Publication number: 20180360950
    Abstract: The present invention generally relates to an immunogenic construct,useful for redirecting an EBV-existing immune response towards an undesired target cell and/or microorganism, to methods for preparing said conjugate, to a pharmaceutical applications comprising said conjugate, and to medical applications thereof.
    Type: Application
    Filed: December 15, 2016
    Publication date: December 20, 2018
    Applicants: Institut National de la Sante et de la Recherche Medicale (INSERM), Centre National de la Recherche Scientifique (CNRS), Universite Paris Diderot Paris 7, Institute National Transfusion Sanguine
    Inventors: Arnaud Chene, Benoit Gamain, Stéphane Gangnard
  • Publication number: 20090130136
    Abstract: The invention is related to the identification of CSA binding domains in var2CSA homologs from different parasite strains and furthermore to an isolated polypeptide comprising a CSA-binding domain sequence substantially as shown in SEQ ID NO:1, or functional equivalent thereof, or the corresponding portion of PfEMP1 from a strain of Plasmodium, substantially in isolation from sequences naturally occurring adjacent thereto in the PfEMP1 protein, and related nucleotide sequences, vectors, host cells, vaccines, and methods of use.
    Type: Application
    Filed: September 30, 2005
    Publication date: May 21, 2009
    Inventors: Louis H. Miller, Benoit Gamain, Joseph D. Smith, Adama R. Trimnell, Christine Scheidig, Artur Scherf
  • Patent number: 6855323
    Abstract: The present invention relates to the discovery of a var gene and corresponding protein that modulates adhesion of parasitized red blood cells to chondroitin sulfate A. Novel biological tools, prophylactics, therapeutics, diagnostics, and methods of use of the foregoing are also disclosed.
    Type: Grant
    Filed: February 21, 2002
    Date of Patent: February 15, 2005
    Assignee: The United States of America as represented by the Department of Health and Human Services
    Inventors: Artur Scherf, Louis H. Miller, Benoit Gamain, Dror I. Baruch, Pierre Buffet, Christine Scheidig, Jurg Gysin, Bruno Pouvelle, Nobutaka Fujii, Joseph Smith
  • Publication number: 20040062769
    Abstract: The present invention relates to the discovery of a var gene and corresponding protein that modulates adhesion of parasitized red blood cells to chondroitin sulfate A. Novel biological tools, prophylactics, therapeutics, diagnostics, and methods of use of the foregoing are also disclosed.
    Type: Application
    Filed: February 21, 2002
    Publication date: April 1, 2004
    Inventors: Arthur Scherf, Louis H. Miller, Benoit Gamain, Dror I. Baruch, Pierre Buffet, Christine Scheidig, Jurg Gysin, Bruno Pouvelle, Nobutaka Fujii, Joseph Smith